141 related articles for article (PubMed ID: 35980802)
61. METTL3 promotes the growth and metastasis of pancreatic cancer by regulating the m6A modification and stability of E2F5.
Tang Y; Gao G; Xia WW; Wang JB
Cell Signal; 2022 Nov; 99():110440. PubMed ID: 35985439
[TBL] [Abstract][Full Text] [Related]
62. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation.
Yue Y; Liu J; He C
Genes Dev; 2015 Jul; 29(13):1343-55. PubMed ID: 26159994
[TBL] [Abstract][Full Text] [Related]
63. METTL3-mediated m6A methylation negatively modulates autophagy to support porcine blastocyst development‡.
Cao Z; Zhang L; Hong R; Li Y; Wang Y; Qi X; Ning W; Gao D; Xu T; Ma Y; Yu T; Knott JG; Sathanawongs A; Zhang Y
Biol Reprod; 2021 May; 104(5):1008-1021. PubMed ID: 33590832
[TBL] [Abstract][Full Text] [Related]
64. METTL3 promotes proliferation of goat endometrial epithelial cells by regulating CTGF in an m6A-dependent manner†.
Sun Y; Zhang XC; Li MD; Bu LG; Wang B; Li TY; Ding NZ; Ni H
Biol Reprod; 2023 Jun; 108(6):902-911. PubMed ID: 36917263
[TBL] [Abstract][Full Text] [Related]
65. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
Wang H; Xu B; Shi J
Gene; 2020 Jan; 722():144076. PubMed ID: 31454538
[TBL] [Abstract][Full Text] [Related]
66. m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.
Ma XX; Cao ZG; Zhao SL
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3565-3571. PubMed ID: 32329830
[TBL] [Abstract][Full Text] [Related]
67. The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma.
Zhu D; Liu Y; Chen J; Wang Q; Li Y; Zhu Y; Feng J; Jiang J
J Transl Med; 2022 Jul; 20(1):298. PubMed ID: 35794583
[TBL] [Abstract][Full Text] [Related]
68. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
Wei K; Gao Y; Wang B; Qu YX
Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
[TBL] [Abstract][Full Text] [Related]
69. METTL3-mediated m6A methylation regulates granulosa cells autophagy during follicular atresia in pig ovaries.
Li Z; Ruan Z; Feng Y; Wang Y; Zhang J; Lu C; Shi D; Lu F
Theriogenology; 2023 Apr; 201():83-94. PubMed ID: 36857977
[TBL] [Abstract][Full Text] [Related]
70. Methyltransferase like 3 promotes colorectal cancer proliferation by stabilizing CCNE1 mRNA in an m6A-dependent manner.
Zhu W; Si Y; Xu J; Lin Y; Wang JZ; Cao M; Sun S; Ding Q; Zhu L; Wei JF
J Cell Mol Med; 2020 Mar; 24(6):3521-3533. PubMed ID: 32039568
[TBL] [Abstract][Full Text] [Related]
71. Role of N6-methyladenosine modification in pathogenesis of ischemic stroke.
Chang H; Yang J; Wang Q; Zhao J; Zhu R
Expert Rev Mol Diagn; 2022 Mar; 22(3):295-303. PubMed ID: 35236212
[TBL] [Abstract][Full Text] [Related]
72. Quercetin ameliorated insulin resistance via regulating METTL3-mediated N6-methyladenosine modification of PRKD2 mRNA in skeletal muscle and C2C12 myocyte cell line.
Jiao Y; Williams A; Wei N
Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2655-2668. PubMed ID: 36058761
[TBL] [Abstract][Full Text] [Related]
73. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
[TBL] [Abstract][Full Text] [Related]
74. METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5.
Zhou D; Tang W; Xu Y; Xu Y; Xu B; Fu S; Wang Y; Chen F; Chen Y; Han Y; Wang G
Mol Oncol; 2021 Aug; 15(8):2172-2184. PubMed ID: 33411363
[TBL] [Abstract][Full Text] [Related]
75. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.
Li D; Fu Z; Dong C; Song Y
Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574
[TBL] [Abstract][Full Text] [Related]
76. RNA N6-methyladenosine methylation and skin diseases.
Yu Y; Lu S; Jin H; Zhu H; Wei X; Zhou T; Zhao M
Autoimmunity; 2023 Dec; 56(1):2167983. PubMed ID: 36708146
[TBL] [Abstract][Full Text] [Related]
77. The m6A-epitranscriptomic signature in neurobiology: from neurodevelopment to brain plasticity.
Widagdo J; Anggono V
J Neurochem; 2018 Oct; 147(2):137-152. PubMed ID: 29873074
[TBL] [Abstract][Full Text] [Related]
78. The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells.
Dixit D; Prager BC; Gimple RC; Poh HX; Wang Y; Wu Q; Qiu Z; Kidwell RL; Kim LJY; Xie Q; Vitting-Seerup K; Bhargava S; Dong Z; Jiang L; Zhu Z; Hamerlik P; Jaffrey SR; Zhao JC; Wang X; Rich JN
Cancer Discov; 2021 Feb; 11(2):480-499. PubMed ID: 33023892
[TBL] [Abstract][Full Text] [Related]
79. Critical Roles of METTL3 in Translation Regulation of Cancer.
Meng W; Xiao H; Mei P; Chen J; Wang Y; Zhao R; Liao Y
Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830614
[TBL] [Abstract][Full Text] [Related]
80. Glaucoma-Associated Mutations in the Optineurin Gene Have Limited Impact on Parkin-Dependent Mitophagy.
Chernyshova K; Inoue K; Yamashita SI; Fukuchi T; Kanki T
Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3625-3635. PubMed ID: 31469402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
